Results 31 to 40 of about 4,527 (138)

Efficacy and Safety of Cataract Surgery Combined with Ab Interno Canaloplasty and Micro-Trabecular Bypass Stent Surgery in Open-Angle Glaucoma [PDF]

Clinical Ophthalmology
Matthew S Porter,1 Addie Flowers,1 Brandon P Wood,1 Mark J Gallardo2 1Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA; 2El Paso Eye Surgeons, El Paso, TX, USACorrespondence: Matthew S Porter, Department of Ophthalmology ...
Porter MS, Flowers A, Wood BP, Gallardo MJ   +3 more
doaj   +2 more sources

Uveitis-Glaucoma-Hyphema Syndrome From Subtle Malposition of a Hydrus Microstent. [PDF]

J Glaucoma
Uveitis-glaucoma-hyphema (UGH) syndrome is a rare condition characterized by intraocular inflammation, elevated intraocular pressure, and recurrent hyphema. Although UGH syndrome is typically caused by chafing between an intraocular lens and the iris or ciliary body, microinvasive glaucoma devices are becoming increasingly recognized as potential ...
Polski A, Long T, Stagg BC, Wirostko B.
europepmc   +3 more sources

Five-Year Outcomes of First-Generation iStent Versus Hydrus Microstent Implantation Combined With Phacoemulsification in Patients With Open-Angle Glaucoma: A Prospective Non-Randomized Comparative Study [PDF]

Journal of Clinical Medicine
Karolina Krix-Jachym, Marek Rekas, Katarzyna Lewczuk   +2 more
exaly   +2 more sources

Hydrus Microstent [PDF]

, 2020
AbstractThe Hydrus®Microstent (Ivantis Inc., Irvine, CA, USA) is an 8-mm intracanalicular scaffold microinvasive glaucoma surgery (MIGS) device which reduces intraocular pressure (IOP) by bypassing the trabecular meshwork and by dilating and scaffolding the Schlemm’s canal.
Panagiotis Laspas, Norbert Pfeiffer
openaire   +1 more source

Microinvasive glaucoma surgery: a review and classification of implant‐dependent procedures and techniques

Acta Ophthalmologica, Volume 100, Issue 2, Page e327-e338, March 2022., 2022
Abstract The aim of this article is to discuss how physiology and anatomical background affect the effectiveness of implant‐dependent microinvasive glaucoma surgery (MIGS). First, we provide a micro view of aqueous outflow and tissue behaviour. Second, we review studies exploring the mechanisms of the pressure‐lowering effect of MIGS, as well as tissue
Joanna Jabłońska, Katarzyna Lewczuk, Joanna Konopińska, Zofia Mariak, Marek Rękas   +4 more
wiley   +1 more source

Corneal Endothelial Cell Loss in Glaucoma and Glaucoma Surgery and the Utility of Management with Descemet Membrane Endothelial Keratoplasty (DMEK)

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
The corneal endothelium has a crucial role in maintaining a clear and healthy cornea. Corneal endothelial cell loss occurs naturally with age; however, a diagnosis of glaucoma and surgical intervention for glaucoma can exacerbate a decline in cell number and impairment in morphology. In glaucoma, the mechanisms for this are not well understood and this
Neeru A Vallabh, Stephnie Kennedy, Riccardo Vinciguerra, Keri McLean, Hannah Levis, Davide Borroni, Vito Romano, Colin E Willoughby, Nilufer Yesilirmak   +8 more
wiley   +1 more source

Comparative Effectiveness and Safety of Two Different Trabecular MIGS Devices With and Without Ab Interno Canaloplasty in Patients with Primary Open-Angle Glaucoma

Ophthalmology and Therapy, 2023
Introduction This study compared outcomes of the iStent inject trabecular micro-bypass system versus the Hydrus Microstent in patients with primary open-angle glaucoma (POAG). Methods Forty subjects (80 eyes) with POAG were included in this single-center,
Mitchell Shultz, Abraham Chorbajian, Ala Zohouralen   +2 more
doaj   +1 more source

Translating Minimally Invasive Glaucoma Surgery Devices

Clinical and Translational Science, Volume 13, Issue 1, Page 14-25, January 2020., 2020
Glaucoma is the leading cause of irreversible blindness with over 70 million people affected worldwide. The surgical management of glaucoma aims to lower intraocular pressure by increasing aqueous outflow facility. The latest manufacturing techniques have allowed for the development of a number of novel implantable devices to improve safety and ...
Richard M.H. Lee, Yann Bouremel, Ian Eames, Steve Brocchini, Peng Tee Khaw   +4 more
wiley   +1 more source

Acute iridocyclitis and cystoid macular edema related to kinked Hydrus® Microstent in advanced glaucoma

Saudi Journal of Ophthalmology, 2022
A 58-year-old male who underwent cataract extraction with combined intraocular lens and Hydrus ® Microstent (Ivantis Inc, Irvine, CA, US) implantation 2 years ago in the right eye (OD) due to advanced glaucoma presented with blurry vision in ...
Karaca, Irmak, Korot, Edward, Ghoraba, Hashem, Regenold, Jonathan, Mobasserian, Azadeh, Khan, Youan, Zaidi, Moosa H., Or, Christopher, Nguyen, Quan D.   +8 more
openaire   +2 more sources

Three-year findings of the HORIZON trial: a Schlemm canal microstent for pressure reduction in primary open angle glaucoma and cataract [PDF]

, 2021
OBJECTIVE: To report 3-year outcomes of the HORIZON study comparing cataract surgery with Hydrus Microstent versus cataract surgery alone. DESIGN: Multicenter randomized clinical trial.
Ong, J, Gazzard, G, Rhee, DJ, HORIZON Investigators, Ahmed, IIK, Jones, J, Radcliffe, N, Singh, IP, Singh, K, Samuelson, TW   +9 more
core   +1 more source